Drug Profile
TRK 750
Alternative Names: TRK-750Latest Information Update: 06 Jan 2023
Price :
$50
*
At a glance
- Originator Toray
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neuropathic pain; Peripheral nervous system diseases
Most Recent Events
- 06 Jan 2023 No development reported - Phase-II for Peripheral nervous system diseases (In the elderly, Chemotherapy-induced, In adults) in United Kingdom (PO)
- 28 Dec 2020 No recent reports of development identified for phase-I development in Neuropathic-pain in United Kingdom (PO, Capsule)
- 23 Jan 2020 Phase-II clinical trials in Peripheral nervous system diseases (Chemotherapy-induced, In adults, In the elderly) in United Kingdom (PO) (EudraCT2019-003561-17)